A Case Report of Autoimmune Haemolytic Anaemia and Acute Hepatitis Associated With Epstein-Barr Virus Infection.
- 1General Medicine, Royal Alexandra Hospital, Paisley, GBR.
Abstract
Infectious mononucleosis is most commonly caused by Epstein-Barr virus (EBV) infection. Although mild hepatic dysfunction is commonly seen, clinically significant acute hepatitis and autoimmune haemolytic anaemia (AIHA) are not seen routinely in clinical practice. The concurrent presentation of both of these poses a diagnostic challenge. A 22-year-old woman presented with jaundice and fatigue following a recent viral illness; she was found to have significant hepatic dysfunction with a peak bilirubin of 344 µmol/L and haemoglobin nadir of 64 g/L. A positive direct antiglobulin test, with blood film findings, supported the diagnosis of AIHA. EBV serology confirmed acute or recent EBV infection, providing a unifying diagnosis. She was managed supportively with no corticosteroids or blood transfusion, under close monitoring and with advice from the haematology team. Her liver function tests and haemoglobin gradually normalised, and follow-up ultrasound demonstrated resolution of splenomegaly. This case highlights the importance of considering EBV for a potential underlying, unifying diagnosis for patients presenting with both AIHA and hepatitis, particularly following a viral prodrome and when other causes have been excluded. Ensuring appropriate haematological investigations are undertaken is essential to guide appropriate management and monitoring.
Related
- Warm autoimmune haemolytic anaemia in Taiwan: A population‐based study of epidemiology, treatment patterns, survival and healthcare utilisation (2017–2022)
- Seroprevalence of Hepatitis B Virus Infection and Associated Factors Among Blood Donors at a District Hospital in Ghana: A 2-Year Retrospective Study
- Immune Checkpoint Inhibitor-Related Hepatitis Versus Classical Autoimmune Hepatitis: A Retrospective Multidomain Phenotype Comparison
- Autoimmune hepatitis following long-term denosumab therapy in a patient with Hashimoto thyroiditis
- Hepatitis B surface antigen clearance in HIV/HBV-coinfected patients: associated clinical factors and a rare amino acid substitution underlying occult infection
BibTeX
@article{wheat2026case,
title = {{A Case Report of Autoimmune Haemolytic Anaemia and Acute Hepatitis Associated With Epstein-Barr Virus Infection.}},
author = {Eve Wheat},
journal = {Cureus},
year = {2026},
month = nov,
doi = {10.7759/cureus.119431},
url = {https://europepmc.org/article/MED/43012022},
note = {CC BY},
}
RIS
TY - JOUR
TI - A Case Report of Autoimmune Haemolytic Anaemia and Acute Hepatitis Associated With Epstein-Barr Virus Infection.
AU - Eve Wheat
PY - 2026
DA - 2026/11/10
JO - Cureus
DO - 10.7759/cureus.119431
UR - https://europepmc.org/article/MED/43012022
AB - Infectious mononucleosis is most commonly caused by Epstein-Barr virus (EBV) infection. Although mild hepatic dysfunction is commonly seen, clinically significant acute hepatitis and autoimmune haemolytic anaemia (AIHA) are not seen routinely in clinical practice. The concurrent presentation of both of these poses a diagnostic challenge. A 22-year-old woman presented with jaundice and fatigue following a recent viral illness; she was found to have significant hepatic dysfunction with a peak bilirubin of 344 µmol/L and haemoglobin nadir of 64 g/L. A positive direct antiglobulin test, with blood film findings, supported the diagnosis of AIHA. EBV serology confirmed acute or recent EBV infection, providing a unifying diagnosis. She was managed supportively with no corticosteroids or blood transfusion, under close monitoring and with advice from the haematology team. Her liver function tests and haemoglobin gradually normalised, and follow-up ultrasound demonstrated resolution of splenomegaly. This case highlights the importance of considering EBV for a potential underlying, unifying diagnosis for patients presenting with both AIHA and hepatitis, particularly following a viral prodrome and when other causes have been excluded. Ensuring appropriate haematological investigations are undertaken is essential to guide appropriate management and monitoring.
SN - 2168-8184
ER -